Pseudomonas bacteria in wound describes an infection caused by Pseudomonas aeruginosa, a Gram-negative bacterium known for causing serious, hard-to-treat infections in open wounds, especially in hospital settings or among people with compromised immune systems.
Pseudomonas aeruginosa thrives in moist environments and is commonly found in soil, water, and hospital surfaces. It gains entry through skin breaches such as surgical incisions, burns, or trauma-related injuries. Once inside, it produces toxins and enzymes that damage tissue and suppress immune responses, leading to delayed healing and systemic spread if untreated.
According to the Centers for Disease Control and Prevention (CDC), Pseudomonas aeruginosa accounts for approximately 10% of all hospital-acquired infections, with higher rates in intensive care units and burn centers. Its ability to form biofilms on medical devices and wound surfaces makes eradication difficult without targeted antimicrobial therapy.
Pseudomonas aeruginosa uses multiple virulence factors to establish infection. It secretes elastase and proteases that degrade collagen and other structural proteins in skin and connective tissue. This weakens wound integrity and promotes deeper invasion.
The bacterium also produces pyocyanin, a blue-green pigment that gives infected wounds a characteristic coloration. This pigment interferes with oxygen delivery to cells and increases oxidative stress, further delaying healing. Clinically, this manifests as foul-smelling, purulent drainage with a distinct sweet-metallic odor.
A 2021 study published in *Clinical Microbiology and Infection* found that 68% of Pseudomonas isolates from chronic wounds showed resistance to at least three classes of antibiotics, including fluoroquinolones and beta-lactams. This multidrug resistance complicates treatment and increases mortality risk.
There are two primary exposure routes for pseudomonas in wound settings:
Wounds most vulnerable include surgical sites (especially abdominal and orthopedic), pressure ulcers, and burns. Burn patients are particularly at risk-up to 30% develop Pseudomonas colonization within 72 hours of admission, according to the National Burn Repository.
Many assume pseudomonas infections only affect immunocompromised individuals. While those with weakened immunity are at higher risk, healthy people can also contract it-especially after trauma or surgery. A 2019 outbreak in a sports clinic involved five athletes who developed infected abrasions after playing on a damp turf field.
Another misconception is that green discharge always indicates Pseudomonas. While pyocyanin production causes greenish pus, other bacteria like Serratia marcescens can produce similar pigments. Accurate diagnosis requires culture and sensitivity testing-not visual inspection alone.
Some confuse Pseudomonas with Archaea. These are entirely different domains of life. Archaea lack cell walls and are often extremophiles found in hydrothermal vents or salt lakes. Pseudomonas is a true bacterium with a peptidoglycan layer and is sensitive to certain antibiotics that do not affect Archaea.
Effective management begins with early detection. Wound cultures should be taken within 24 hours of suspicion, using swabs from the deepest viable tissue. Blood cultures are recommended if fever or sepsis signs appear.
First-line treatment involves antipseudomonal beta-lactams such as piperacillin-tazobactam or ceftazidime. For resistant strains, combination therapy with aminoglycosides (e.g., gentamicin) or carbapenems (e.g., meropenem) is required. Resistance patterns vary by region-some hospitals report >50% resistance to ciprofloxacin.
Consider this clinical scenario: A 65-year-old man with diabetes develops a foot ulcer after stepping on a nail. The wound shows yellow-green exudate and surrounding erythema. A culture grows Pseudomonas aeruginosa with resistance to ampicillin and cefazolin. He is started on intravenous ceftazidime and oral ciprofloxacin. After seven days, the wound shows reduced drainage and granulation tissue formation. By day 14, the wound is closed and culture-negative.
Debridement remains essential. Surgical removal of necrotic tissue reduces bacterial load and improves antibiotic penetration. Negative-pressure wound therapy (NPWT) has shown success in reducing infection recurrence by up to 40% in randomized trials.
Standard precautions reduce transmission. Healthcare workers must use gloves and gowns when handling wounds, and surfaces should be disinfected with bleach-based solutions-Pseudomonas survives on dry surfaces for up to 72 hours.
For patients, keeping wounds covered and avoiding exposure to standing water is critical. Diabetics should inspect feet daily and seek care at the first sign of breakage. A 2020 CDC guideline recommends screening high-risk patients for colonization prior to major surgery.
I once treated a burn patient whose wound became colonized with Pseudomonas after a nurse used a contaminated saline bottle. Despite initial improvement, the infection recurred. Only after switching to single-use vials and adding topical silver sulfadiazine did the wound heal completely. That case reinforced the importance of sterile technique in wound care.